BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3432163)

  • 1. Pharmacokinetics of apovincaminic acid in dogs.
    Vereczkey L; Pudleiner P
    Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
    Miskolczi P; Vereczkey L; Szalay L; Göndöc C
    Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic metabolism of vinpocetine in the rat.
    Vereczkey L; Szentirmay Z; Szporny L
    Arzneimittelforschung; 1979; 29(6):953-6. PubMed ID: 582790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
    Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of vinpocetine (Cavinton) in dog.
    Polgár M; Vereczkey L
    Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinpocetine pharmacokinetics in elderly subjects.
    Grandt R; Beitinger H; Schaltenbrand R; Braun W
    Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the absorption of vinpocetine and apovincaminic acid.
    Pudleiner P; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of vinpocetine in humans.
    Vereczkey L; Czira G; Tamás J; Szentirmay Z; Botár Z; Szporny L
    Arzneimittelforschung; 1979; 29(6):957-60. PubMed ID: 582791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
    Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
    Miskolczi P; Kozma K; Polgár M; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and disposition of vinpocetine in rats].
    Yao JH; Su CY; Chu XY
    Yao Xue Xue Bao; 1994; 29(2):81-5. PubMed ID: 8042515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and metabolic studies of vinpocetine on dogs. I. Pharmacokinetics.
    Szeleczky G; Vereczkey L
    Pol J Pharmacol Pharm; 1986; 38(3):257-67. PubMed ID: 3774624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous evaluation of apovincaminic acid esters and their metabolite apovincaminic acid by solvent partition and GLC in biological samples. Preliminary data with MR 711.
    Marzo A; Quadro G; Stradi R; Saccarello ML; Molteni L; Bruno G
    Arzneimittelforschung; 1981; 31(10):1681-4. PubMed ID: 7198444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and metabolic studies of vinpocetine on dogs. II. Metabolism.
    Szeleczky G; Vereczkey L
    Pol J Pharmacol Pharm; 1986; 38(3):269-75. PubMed ID: 3774625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography.
    Maya MT; Pais JP; Araújo HM; Morais JA
    J Pharm Biomed Anal; 1996 Mar; 14(5):617-22. PubMed ID: 8738192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of vinpocetine on brain glucose uptake in mice].
    Shibota M; Kakihana M; Nagaoka A
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):221-4. PubMed ID: 7152391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of noreximide in the beagle dog.
    Koch HP; Bykadi G; Ledesma B; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1982; 4(8):587-90. PubMed ID: 7169847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tramadol, and its metabolite O-desmethyl-tramadol, in cats.
    Pypendop BH; Ilkiw JE
    J Vet Pharmacol Ther; 2008 Feb; 31(1):52-9. PubMed ID: 18177319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.